BOT fundamentals
An in-depth look to BOTANIX PHARMACEUTICALS LTD operating, investing, and financing activities
BOT free cash flow for H1 25 is -30.65 M AUD. For 2024, BOT free cash flow was -8.24 M AUD and operating cash flow was -8.13 M AUD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
TTM